Transmission of HIV-1 Drug Resistance

Speaker:

Sharon Karmon, MD,

The Center for Clinical and Translational Science (CCTS), The Rockefeller University
Learning Objectives:
1. Describe the nature of transmitted HIV-1 drug resistance
2. Discuss the benefits and limitations of using standard Sanger sequencing to characterize HIV-1 drug resistance mutations
3. Discuss the benefits and limitations of using ultra-deep sequencing methods to characterize HIV-1 drug resistance mutations
Sponsor: Rockefeller University Date/Time: Tuesday, July 17th, 2012, 2:00 – 3:00 PM EST

Recent Webcasts

Sex in the Time of COVID-19

Presenter:
Kenneth H. Mayer, M.D., Medical Research Director, Fenway Health, Co-Director, The Fenway Institute, Professor of Medicine, Harvard Medical School, Attending Physician, Infectious Disease...

Opioid Prescribing in the COVID-19 Era

Presenters:
Joanna L. Starrels, MD, MS, FACP, Associate Professor of Medicine, Albert Einstein College of Medicine and Montefiore Medical Center, Division of General Internal Medicine
Hector R. Perez,...

Prescription Pain Medication Use in the Community

Presenter:
Linda B. Cottler, PhD, MPH, FACE, Associate Dean for Research, College of Public Health and Health Professions and Dean's Professor of Epidemiology at the University of Florida
Sponsored...